Penumbra (FRA:0P8) 3-Year Revenue Growth Rate : 19.90% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Penumbra 3-Year Revenue Growth Rate?

Penumbra's Revenue per Share for the three months ended in Dec. 2023 was €6.64.

During the past 12 months, Penumbra's average Revenue per Share Growth Rate was 20.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 16.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Penumbra was 63.70% per year. The lowest was -2.00% per year. And the median was 19.90% per year.

Competitive Comparison of Penumbra's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Penumbra's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Penumbra's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Penumbra's 3-Year Revenue Growth Rate falls into.

Penumbra 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Penumbra (FRA:0P8) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Penumbra 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Penumbra's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Penumbra (FRA:0P8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (FRA:0P8) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

PEN:USA PEN:Mexico 0P8:Germany

Address

One Penumbra Place, Alameda, CA, USA, 94502

Website

https://www.penumbrainc.com

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

Penumbra (FRA:0P8) Headlines

No Headlines